The aluminum used in wastewater treatment and its possible relationship with Alzheimer's disease
DOI:
https://doi.org/10.19230/jonnpr.1704Keywords:
Aluminum, Alzheimer’s disease, CoagulationAbstract
Alzheimer's disease (AD) is clinically characterized as a cause of dementia present in older adults. Patients may experience anxiety and depression. Aluminum (Al) is a common metal in the environment and one of the most abundant. Most of Al ingestion comes from food, through different forms: food contaminated by Al, water and industrialized foods that have Al as a preservative and / or coloring, the water being the most bioavailable form to be absorbed by the intestine. Al is extremely proinflammatory, pathological and genotoxic, which is particularly detrimental to the homeostatic functioning of brain cells, especially at the level of normal cytoplasmic and genetic activities using phosphate. Its ingestion can lead to gradual loss of memory. Based on the above, the objective of the present work is to show systematically revised information from published studies related to the intake of aluminum and Alzheimer's disease.
Downloads
References
Yokel RA. The toxicology of aluminum in the brain: a review. Neurotoxicology 2000; 21(5): 813-28.
Suay L, Ballester F. Revisión de los estudios sobre exposición al aluminio y enfermedad de alzheimer. Rev. Esp. Salud Public 2002; 76: 645-58.
Banegas J. Enfermedad de alzheimer. BUN Synapsis 2007; 2: 4-11.
Coon KD, Myers AJ, DW C, Webster JA, Pearson JV, Lince DH , et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiat 2007; 68(4 ): 613–8.
11. Guo Z, Cupples LA, Kurz A, Auerbach SH, Volicer L, Chui H, et al. Head injury and the risk of AD in the MIRAGE study. Neurology 2000; 54(6): 1316–23.
12. Calderón-Garcidueñas L, Reed W, Maronpot RR, Henriquez-Roldán C, Delgado-Chavez R, Calderón-Garcidueñas A , et al. Brain Inflammation and Alzheimer's-Like Pathology in Individuals Exposed to Severe Air Pollution. Toxicologic Pathol 2004; 32(6 ): 650–8.
Tyas SL, Manfreda J, Strain LA, Montgomery PR. Risk factors for Alzheimer’s disease: a population-based, longitudinal study in Manitoba, Canada. Int J Epidemiol 2001; 30(3): 590-7.
Soni MG, White SM, Flamm WG, Burdock GA. Safety evaluation of dietary aluminum. Regul Toxicol Pharmacol 2001; 33(1): 66-79.
Bondy SC. Low levels of aluminum can lead to behavioral and morphological changes associated with Alzheimer’s disease and age- related neurodegeneration. Neurotoxicology 2016; 52: 222–9.
Crisponi G, et al. The meaning of aluminium exposure on human health and aluminium-related diseases. Biomol Concepts 2013; 4(1): 77- 87.
Trejo R, Hernández V. Riesgos a la salud por presencia del aluminio en el agua potable. Conciencia Tecnológica 2004; 25: 1-2.
Bates AJ. Water as consumed and its impact on the consumer-do we understand the variables? Food Chem Toxicol, 2000; 38: 29-36.
WHO, Aluminium in drinking-water. Background document for development of WHO Guidelines for Drinking-water Quality, Geneva 2010.
Becaria A, Lahiri DK, Bondy SC, Chen D, Hamadeh A, Li H, Taylor R, Campbell A. Aluminum and copper in drinking water enhance inflammatory or oxidative events specifically in the brain. J Neuroimmunol 2006; 176: 16–23.
Walton JR, Wang MX. APP expression, distribution and accumulation are altered by aluminum in a rodent model for Alzheimer's disease. J Inorg Biochem2009; 103: 1548-54.
Exley C. The aluminium-amyloid cascade hypothesis and Alzheimer's disease. Subcell Biochem 2005; 38: 225-34.
Lukiw WJ, Pogue AI. Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J Inorg Biochem, 2007; 101: 1265-69.
Pogue AI, Li YY, Cui JG, Zhao Y, Kruck TP, Percy ME, Tarr MA, Lukiw WJ. Characterization of an NF-kappaBregulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells. J Inorg Biochem 2009; 103:1591-95.
Alexandrov PN, Zhao Y, Pogue AI, Tarr MA, Kruck TPA, Percy ME, Cui JG, Lukiw WJ. Synergistic effects of iron and aluminum on stress-related gene expression in primary human neural cells. J Alzheimer’s Dis 2005; 8: 117-27.
Lukiw WJ, Bazan NG. Inflammatory, apoptotic, and survival gene signaling in Alzheimer's disease. A review on the bioactivity of neuroprotectin D1 and apoptosis. Mol Neurobiol 2010; 42(1): 10-6.
Bhattacharjee S, Zhao Y, Hill JM, Culicchia F, Kruck TPA, Percy ME, Pogue AI, Walton JR, Lukiw WJ. Selective accumulation of aluminum in cerebral arteries in Alzheimer’s disease (AD). J Inorg Biochem 2013; 126: 35-7.
Walton JR. Chronic aluminum intake causes Alzheimer's disease: applying Sir Austin Bradford Hill's causality criteria. J Alzheimers Dis 2014; 40(4): 765-838.
Morris G, Puri BK, Frye RE. The putative role of environmental aluminium in the development of chronic neuropathology in adults and children. How strong is the evidence and what could be the mechanisms involved?. Metab Brain Dis, 2017; doi: 10.1007/s11011-017-0077-2.
Polizzi S, Pira E, Ferrara M, Bugiani M, Papaleo A, Albera R, Palmi S. Neurotoxic effects of aluminum among foundry workers and Alzheimer's
disease. Neurotoxicology, 2002; 23: 761-74.
Shirabe T, Irie K, Uchida M.Autopsy case of aluminum encephalopathy. Neuropathol, 2002; 22: 206-10.
Martyn CN, Coggan D, Inskip H, Lacey RF, Young WF. Aluminum concentrations in drinking water and risk of Alzheimer’s disease. Epidemiology, 1997; 8(3): 281-6.
Forster DP, Newens AJ, Kay DW, Edwardson JA. Risk factors in clinically diagnosed presenile dementia of the Alzheimer type: a case- control study in northern England. J Epidemiol Community Health, 1995; 49(3): 253-8.
Exley C, Vickers T. Elevated brain aluminium and early onset Alzheimer’s disease in an individual occupationally exposed to aluminium: a case report. J Med Case Rep, 2014; 8: 41.10.1186/1752-1947-8-4.
Exley C, Esiri M. Severe cerebral congophilic angiopathy coincident with increased brain aluminium in a resident of Camelford, Cornwall, UK. J Neurol Neurosurg Psychiatry, 2006; 77: 877–9.10.1136/jnnp.2005.086553.
Additional Files
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
